Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder

NCT05683184 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT05683184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05683184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Recruiting
Start date
March 10, 2023
Completion date
December 15, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy control, opioid use disorder